Literature DB >> 16905729

Is an internal comparison better than using national data when estimating mortality in longitudinal studies?

T R Card1, M Solaymani-Dodaran, R Hubbard, R F A Logan, J West.   

Abstract

BACKGROUND: Discrepancies between the results of different studies looking at mortality in similar disease cohorts led us to consider the impact of methodology upon outcome.
METHODS: Cohort studies were carried out using age, sex, practice, and calendar time matched control groups in the general practice research database. Data were used on all subjects with inflammatory bowel disease, coeliac disease, or Barrett's oesophagus. Mortality data for the population of England and Wales were obtained from the UK Office for National Statistics. The study compared hazard ratios (HR) for mortality using the matched controls to those found when an indirect standardisation to the mortality experience of England and Wales was carried out.
RESULTS: For all three conditions the mortality risk was slightly lower when the national population data were used compared with the internal comparison group (coeliac disease HR 1.33 v standardised mortality ratios (SMR) 1.25, Barrett's oesophagus HR 1.32 v SMR 1.32, inflammatory bowel disease HR 1.50 v SMR 1.34).
CONCLUSIONS: A bias was found towards underestimating mortality risk when cohort studies use national population death rates as a comparator. Estimates obtained when an internal comparison group has been used are probably more appropriate.

Entities:  

Mesh:

Year:  2006        PMID: 16905729      PMCID: PMC2566035          DOI: 10.1136/jech.2005.041202

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  8 in total

1.  The UK General Practice Research Database.

Authors:  T Walley; A Mantgani
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

2.  Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface.

Authors:  A J McMichael
Journal:  J Occup Med       Date:  1976-03

3.  The General Practice Research Database: quality of morbidity data.

Authors:  J Hollowell
Journal:  Popul Trends       Date:  1997

4.  Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Cheng Cheng; Wing Leung; Shesh N Rai; Gaston K Rivera; John T Sandlund; Raul C Ribeiro; Mary V Relling; Larry E Kun; William E Evans; Melissa M Hudson
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

5.  Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

Authors:  Karen Vanessa Winther; Tine Jess; Ebbe Langholz; Pia Munkholm; Vibeke Binder
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

6.  Mortality in inflammatory bowel disease: a population-based cohort study.

Authors:  Tim Card; Richard Hubbard; Richard F A Logan
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

7.  Mortality in a long-term open cohort of prostitute women.

Authors:  John J Potterat; Devon D Brewer; Stephen Q Muth; Richard B Rothenberg; Donald E Woodhouse; John B Muth; Heather K Stites; Stuart Brody
Journal:  Am J Epidemiol       Date:  2004-04-15       Impact factor: 4.897

8.  Malignancy and mortality in people with coeliac disease: population based cohort study.

Authors:  Joe West; Richard F A Logan; Chris J Smith; Richard B Hubbard; Timothy R Card
Journal:  BMJ       Date:  2004-07-21
  8 in total
  12 in total

1.  Analysis of mortality in chrysotile asbestos miners in China.

Authors:  Lili Du; Xiaorong Wang; Mianzhen Wang; Yajia Lan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

2.  Psoriasis and cardiovascular risk: strength in numbers, part II.

Authors:  Joel M Gelfand; Nehal N Mehta; Sinéad M Langan
Journal:  J Invest Dermatol       Date:  2011-05       Impact factor: 8.551

Review 3.  Perinatal program evaluations: methods, impacts, and future goals.

Authors:  Suzanne D Thomas; Jodi L Hudgins; Donald E Sutherland; Brittany L Ange; Sandra C Mobley
Journal:  Matern Child Health J       Date:  2015-07

4.  Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

Authors:  Jennifer J Y Lee; Brian M Feldman; Brian W McCrindle; Ping Li; Rae Sm Yeung; Jessica Widdifield
Journal:  Pediatr Res       Date:  2022-08-24       Impact factor: 3.953

5.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

6.  Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.

Authors:  Alexis Ogdie; Kevin Haynes; Andrea B Troxel; Thorvardur Jon Love; Sean Hennessy; Hyon Choi; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2012-12-21       Impact factor: 19.103

7.  Clinical significance of colonoscopy in patients with upper gastrointestinal polyps and neoplasms: a meta-analysis.

Authors:  Zhen-Jie Wu; Yuan Lin; Jun Xiao; Liu-Cheng Wu; Jun-Gang Liu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

8.  Allergic conditions are not associated with the risk of non-Hodgkin's lymphoma or Hodgkin's lymphoma: a systematic review and meta-analysis.

Authors:  Jia Yang; Hong'en Xu; Xiaodong Liang; Shiliang Lv; Baihua Lin; Yongshi Jia
Journal:  Onco Targets Ther       Date:  2017-04-18       Impact factor: 4.147

Review 9.  Mortality in congenital hemophilia A - a systematic literature review.

Authors:  Charles R M Hay; Francis Nissen; Steven W Pipe
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

10.  Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community.

Authors:  J A 'Chris' Delaney; Verena Schneider-Lindner; Paul Brassard; Samy Suissa
Journal:  BMC Med       Date:  2008-01-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.